tag psychiatry 
pharmaphorum
DECEMBER 7, 2021
That finding could provide some comfort to Biogen and Eisai, whose recently-approved amyloid-targeting drug Aduhelm (aducanumab) is struggling to gain traction in the market on the back of unconvincing efficacy data, safety concerns and a high price tag.
The Physician Pharmacist
SEPTEMBER 14, 2023
You will be evaluated with your GPA side by side as someone who did philosophy as an undergraduate or psychiatry. Speaker 2 So I'm in a fairly, I was in a fairly unique situation, my GPA coming out of pharmacy school was not great. So where they were getting a 4.0,
Expert insights. Personalized for you.
52 
Let's personalize your content